Tumor immune microenvironmental alterations occur early in multiple myeloma (MM) development. In this study, we aim to systematically characterize the tumor immune microenvironment (TME) and the tumor
All data are median (interquartile range); All comparisons were made to FI/II: *p≤0.05, **p≤0.01 and ***p≤0.001; CHI: Chronically HIV-infected patients; DR: HLA-DR. Percentage of activated (HLA-DR+CD3